|
1
|
Solomon A, Frangione B and Franklin EC:
Bence Jones proteins and light chains of immunoglobulins.
Preferential association of the V lambda VI subgroup of human light
chains with amyloidosis AL (lambda). J Clin Invest. 70:453–460.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kumar SK, Dispenzieri A, Lacy MQ, Gertz
MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, et
al: Continued improvement in survival in multiple myeloma: Changes
in early mortality and outcomes in older patients. Leukemia.
28:1122–1128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aggarwal R, Ghobrial IM and Roodman GD:
Chemokines in multiple myeloma. Exp Hematol. 34:1289–1295. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jurczyszyn A, Czepiel J, Biesiada G,
Gdula-Argasińska J, Cibor D, Owczarek D, Perucki W and Skotnicki
AB: HGF, sIL-6R and TGF-β1 play a significant role in the
progression of multiple myeloma. J Cancer. 5:518–524. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Toh B, Wang X, Keeble J, Sim WJ, Khoo K,
Wong WC, Kato M, Prevost-Blondel A, Thiery JP and Abastado JP:
Mesenchymal transition and dissemination of cancer cells is driven
by myeloid-derived suppressor cells infiltrating the primary tumor.
PLoS Biol. 9:e10011622011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ungefroren H, Groth S, Sebens S, Lehnert
H, Gieseler F and Fändrich F: Differential roles of Smad2 and Smad3
in the regulation of TGF-β1-mediated growth inhibition and cell
migration in pancreatic ductal adenocarcinoma cells: Control by
Rac1. Mol Cancer. 10:672011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim HS, Shang T, Chen Z, Pflugfelder SC
and Li DQ: TGF-beta1 stimulates production of gelatinase (MMP-9),
collagenases (MMP-1, -13) and stromelysins (MMP-3, -10, -11) by
human corneal epithelial cells. Exp Eye Res. 79:263–274. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hideshima T, Richardson P, Chauhan D,
Palombella VJ, Elliott PJ, Adams J and Anderson KC: The proteasome
inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes
drug resistance in human multiple myeloma cells. Cancer Res.
61:3071–3076. 2001.PubMed/NCBI
|
|
12
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tanaka H, Shinto O, Yashiro M, Yamazoe S,
Iwauchi T, Muguruma K, Kubo N, Ohira M and Hirakawa K: Transforming
growth factor β signaling inhibitor, SB-431542, induces maturation
of dendritic cells and enhances anti-tumor activity. Oncol Rep.
24:1637–1643. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsuyama S, Iwadate M, Kondo M, Saitoh M,
Hanyu A, Shimizu K, Aburatani H, Mishima HK, Imamura T, Miyazono K
and Miyazawa K: SB-431542 and Gleevec inhibit transforming growth
factor-beta-induced proliferation of human osteosarcoma cells.
Cancer Res. 63:7791–7798. 2003.PubMed/NCBI
|
|
15
|
He Y, Huang C, Sun X, Long XR, Lv XW and
Li J: MicroRNA-146a modulates TGF-beta1-induced hepatic stellate
cell proliferation by targeting SMAD4. Cell Signal. 24:1923–1930.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu X, Li P, Liu P, Xiong R, Zhang E, Chen
X, Gu D, Zhao Y, Wang Z and Zhou Y: The essential role for c-Ski in
mediating TGF-beta1-induced bi-directional effects on skin
fibroblast proliferation through a feedback loop. Biochem J.
409:289–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bergfeld SA and DeClerck YA: Bone
marrow-derived mesenchymal stem cells and the tumor
microenvironment. Cancer Metastasis Rev. 29:249–261. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sawada T, Kimura K, Nishihara T, Onoda N,
Teraoka H, Yamashita Y, Yamada N, Yashiro M, Ohira M and Hirakawa
K: TGF-beta1 down-regulates ICAM-1 expression and enhances liver
metastasis of pancreatic cancer. Adv Med Sci. 51:60–65.
2006.PubMed/NCBI
|
|
19
|
Biswas S, Guix M, Rinehart C, Dugger TC,
Chytil A, Moses HL, Freeman ML and Arteaga CL: Inhibition of TGF-β
with neutralizing antibodies prevents radiation-induced
acceleration of metastatic cancer progression. J Clin Invest.
127:11162017. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bacman D, Merkel S, Croner R, Papadopoulos
T, Brueckl W and Dimmler A: TGF-beta receptor 2 downregulation in
tumour-associated stroma worsens prognosis and high-grade tumours
show more tumour-associated macrophages and lower TGF-beta1
expression in colon carcinoma: A retrospective study. BMC Cancer.
7:1562007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Radisky DC, Levy DD, Littlepage LE, Liu H,
Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, et
al: Rac1b and reactive oxygen species mediate MMP-3-induced EMT and
genomic instability. Nature. 436:123–127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Casey TM, Eneman J, Crocker A, White J,
Tessitore J, Stanley M, Harlow S, Bunn JY, Weaver D, Muss H and
Plaut K: Cancer associated fibroblasts stimulated by transforming
growth factor beta1 (TGF-beta 1) increase invasion rate of tumor
cells: A population study. Breast Cancer Res Treat. 110:39–49.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fuxe J, Vincent T and de Herreros A
Garcia: Transcriptional crosstalk between TGF-β and stem cell
pathways in tumor cell invasion: Role of EMT promoting Smad
complexes. Cell Cycle. 9:2363–2374. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen S, Zhu J, Zuo S, Ma J, Zhang J, Chen
G, Wang X, Pan Y, Liu Y and Wang P: 1,25(OH)2D3 attenuates
TGF-β1/β2-induced increased migration and invasion via inhibiting
epithelial-mesenchymal transition in colon cancer cells. Biochem
Biophys Res Commun. 468:130–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blavier L, Lazaryev A, Shi XH, Dorey FJ,
Shackleford GM and DeClerck YA: Stromelysin-1 (MMP-3) is a target
and a regulator of Wnt1-induced epithelial-mesenchymal transition
(EMT). Cancer Biol Ther. 10:198–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Robichaud N, Del Rincon SV, Huor B, Alain
T, Petruccelli LA, Hearnden J, Goncalves C, Grotegut S, Spruck CH,
Furic L, et al: Phosphorylation of eIF4E promotes EMT and
metastasis via translational control of SNAIL and MMP-3. Oncogene.
34:2032–2042. 2015. View Article : Google Scholar : PubMed/NCBI
|
